NCT00793156
A Randomized-Withdrawal Phase 3 Study Evaluating the Safety and Efficacy of Oral Nalfurafine HCl (AC-820)in Subjects on Hemodialysis With Uremic Pruritus (Renal Itch)
Phase: Phase 3
Role: Lead Sponsor
Start: Dec 31, 2009
Completion: Mar 31, 2011